Tele-Induction of Buprenorphine for Opioid Use Disorder: Regulatory Flux and Public Confusion – Fordham Law Review

Symposium

Tele-Induction of Buprenorphine for Opioid Use Disorder: Regulatory Flux and Public Confusion

October 31, 2024

Tags: buprenorphine, Covid-19, health care, healthcare, opioid use disorder, patients, prescription, providers, public health, regulations, regulatory, rules, tele-induction, telehealth, telemedicine, temporary, uncertainty

Related Reads

Symposium

Psychedelics, Psychosocial Support, and Psychotherapy: Why It Matters for the Law, Ethics, and Business of Medical Psychedelic Use

By I. Glenn Cohen

Time to Abolish the DEA: Evaluating the Agency’s Failures and Calling for Community Investments

By Ifetayo Harvey

State Drug Laws

Marijuana and the Tyrannies of Scheduling

By Robert A. Mikos

Expecting Medication Surveillance

By Jennifer D. Oliva

Join Our Mailing List